## 

## 



## 

## 

||`Page`|
|---|---|
|`ReportoftheTrustees’`|`1-2`|
|`IndependentExaminer'sReport`|`3`|
|`StatementofFinancialActivities`|`4`|
|`BalanceSheet`|`5`|
|`NotestoAccounts`|`6-8`|
|`ScheduleofInvestments`|`9`|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 




## 

## 

## 

## 



## 

|||||`2023`|`2022`|
|---|---|---|---|---|---|
|||`Unrestricted`|`Expendable`|`Total`|`Total`|
|||`fund`|`endowment`|||
||`Note`|||||
|||`£`|`£`|`E`|`E`|
|`Incomeandexpenditure`||||||
|`Incomingresources`||||||
|`Incomefrom:`||||||
|`Donations`|`2`|`-`|`42,190`|`42,190`|`20,000`|
|`Giftaidreceived`|`2`|`-`|`10,567`|`10,567`|`-`|
|`Investments`|`2`|`838`|`-`|`838`|`711`|
|`Total`||<br> <br>`838`|<br> <br>`52,757`|<br> <br>`53,595`|<br> <br>`20,711`|
|`Resourcesexpended`||||||
|`Directcharitableexpenditure:`||||||
|`Grants/Donations`|`3`|<br>`:`|<br>`59,570`|<br>`59,570`|<br>`42,085`|
|`Otherexpenditure`<br>`:`||||||
|`Management.andadministration`|`4`|`2,680`|`-`|`2,680`|`2,786`|
|`Totalexpenditure`||<br> <br>`2,680`|<br> <br>`59,570`|<br> <br>`62,250`|<br> <br>`44,871`|
|`Netincome/(expenditure)`||||||
|`beforeinvestmentgains/(losses)`||`(1,842)`|`(6,813)`|`(8,655)`|`(24,160)`|
|`Netgains/(losses)oninvestments`||||||
|`Realised`||`-`|`4,569`|`4,569`|`-`|
|`Unrealised`||`-`|`(38,581)`|`(38,581)`|`920`|
|`Totalinvestmentgains`|`6`|<br> <br>`-`|<br> <br>`(34,012)`|<br> <br>`(34,012)`|<br> <br>`920`|
|`Transfersbetweenfunds`|`9`|<br>`2,450`|<br>`(2,450)`|<br>`-`|<br>`:`|
|`Netmovementinfunds`||`608`|`(43,275)`|`(42,667)`|`(23,240)`|
|`Reconciliationoffunds`||||||
|`Totalfundsbroughtforwardat6 April2022`||`630`|`202,835`|`203,465`|`226,705`|
|`Totalfundscarriedforwardat5 April2023`||<br>`1,238`<br>|<br>`159,560`<br>|<br>`160,798`<br>|<br>`203,465`<br>|





## 

## 

||||||`2023`|`2022`|
|---|---|---|---|---|---|---|
||||`Unrestricted`|`Expendable`|||
||`Note`||`fund`|`endowment`|`Total`|`Total`|
||||`£`|`£`|`£`|`E`|
|`Fixedassets`|||||||
|`Investments( atmarketvalue)`||<br>`6`|<br>`-`|<br>`104,558`|<br>`104,558`|<br>`190,800`|
|`Currentassets`|||||||
|`Incometaxrecoverable`|||`-`|`-`|`-`|`1,250`|
|`Cashatbankandinhand`||`7`|`4,718`|`57,582`|`62,300`|`15,875`|
||||<br>`4,718`|<br>`57,582`|<br>`62,300`|<br>`17,125`|
|`Creditors:amountsfallingduewithin`|`one`|`year`|||||
|`Accruals`|`8`||`3,480`|`2,580`|`6,060`|`4,460`|
|`Netcurrentassets`||<br>|<br> <br>`1,238`|<br> <br>`55,002`|<br> <br>`56,240`|<br> <br>`12,665`|
|`Totalassetslesscurrentliabilities`|||<br>`1,238`|<br>`159,560`|<br>`160,798`|<br>`203,465`|
||||||`2023`|`2022`|
||||`Unrestricted`|`Expendable`|||
|`FundsoftheCharity`|||`fund`|`endowment`|`Total`||
||||`£`|`£`|`£`|`£`|
|`Totalfunds`|`9`|<br>|`1,238`<br>|`159,560`<br>|`160,798`<br>|`203,465`<br>|





## 

## 

## 

## 



## 

## 

|||||`2023`||`2022`||
|---|---|---|---|---|---|---|---|
|||`Unrestricted`|`Expendable`|||||
|`2.`|`Incomereceived`|`fund`|`endowment`|`Total`||`Total`||
|||`£`|`£`|`£`||`£`||
||`Donations`|||||||
||`CAFdonationsreceived`|`-`|`-`||`:`||`-`|
||`Investmentdonationsreceived`|<br>`-`|<br>`42,190`|<br>`42,190`|<br>|<br>`20,000`|<br>|
|||<br>`-`|<br>`42,190`|<br>`42,190`|<br>|<br>`20,000`|<br>|
||`Giftaidreceived`|`-`|`10,567`|`10,567`|||`-`|
||`Investmentincome`|||||||
||`Dividendsreceived`|`838`|`-`|`838`||`711`||
|||<br> <br>`838`|<br> <br>`52,757`|<br> <br>`53,595`|<br> <br>|<br> <br>`20,711`|<br> <br>|
|||||`2023`||`2022`||
|`3.`|`Directcharitableexpenditure`|`Unrestricted`|`|Expendable`|`Total`||`Total`||
|||`fund`|`endowment`|||||
|||`£`|`£`|`£`||`£`||
||`Charitabledonations`|||||||
||`SuffolkCommunityFoundation`|`-`|`50,000`|`50,000`||`25,000`||
||`FreshStartNewBeginnings`|`-`|`-`|`-`||`2,300`||
||`Lepra`|`-`|`-`|`-`||`2,500`||
||`BuresCommunityCentre`|`-`|`-`|`:`||`385`||
||`Stoke-by-Nayland- StMary`|`~`|`-`|`-`||`1,000`||
||`DominicBarketTrust`|`-`|`-`|`-`||`200`||
||`WedmarHospiceCare`|`-`|`-`|`-`||`6,700`||
||`ReachcommunityPR`|`-`|`-`|`-`||`3,000`||
||`PriscillaBacon Hospice`|`-`|`1,000`|`1,000`||`1,000`||
||`SAS"StrokeAfterSuccess"`|`-`|`570`|`570`||`-`||
||`ReachHorchill`|`-`|`3,000`|`3,000`||`-`||
||`MusicinOurBones`|<br>`-`|<br>`5,000`|<br>`5,000`||<br>`:`|<br>|
|||<br> <br>`:`|<br> <br>`59,570`|<br> <br>`59,570`|<br>|<br> <br>`42,085`|<br>|
|||||`2023`||`2022`||
|||`Unrestricted`|`Expendable`|||||
|`4,`|`Administrativeexpenses`|`fund`|`endowment`|`Total`||`Total`||
|||`£`|`£`|`£`||`£`||
||`Managementandadministration:`|||||||
||`Independentexaminationfee`|`230`|`-`|`230`||`220`||
||`Accountancyfee`|`1,730`|`-`|`1,730`||`1,500`||
||`Investmentmanagementexpenses`|`720`|`-`|`720`||`1,066`||
|||<br>`2,680`<br>|<br>`-`<br>|<br>`2,680`<br>|<br>|<br>`2,786`<br>|<br> <br>|





## 

||||||||||||||`2023`|`2022`|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|`6.`|`Investmentsheldasfixedassets`||||||||`fund`|||`endowment`|`Total`|`Total`|
||||||||||`E`|||`£`|`£`|`£`|
||`Marketvalue6 April2022`<br>`Additionsatcost`<br>`Disposalsatopeningmarketvalue`||||||||||`-`<br>`.`<br>`-`|`190,800`<br>`40`<br>`(47,701)`|`190,800`<br>`40`<br>`(47,701)`|`153,970`<br>`35,910`<br>`-`|
||`Netunrealisedinvestmentgains/(losses)}`<br>`Marketvalueat5 April2023`||||||||<br>|<br>|<br> <br>`:`<br>`-`|<br> <br>`(38,581)`<br>`104,558`|<br> <br>`(38,581)`<br>`104,558`|<br> <br>`920`<br>`190,800`|
||`Costat5 April2023`||||||||||`-`<br>|`95,429`<br>|`95,429`<br>|`143,090.`<br>|
||`Investmentswererevaluedatmiddlemarket`|`value`|`atthe`||`yearend,`|||`Allinvestments`||`are`|`held`|`withintheexpendableendowment`||`fund.The`|
||`portfolioisheldinEquitiesandFundsmanagedbystockbrokers,J `||||||`M`|`Finn.`|||||||
||||||||||||||`2023`|`2022`|
||`Investmentsheldin:`||||||||||||`£`|`£`|
||`NorthAmerica`<br>`UK`<br>`Europe`<br>`Global`<br>`AlternativeStrategies`<br>`Marketvalueat5 April2023`||||||||||||<br> <br>`10,546`<br>`11,661`<br>`21,392`<br>`46,964`<br>`13,995`<br>`104,558`|<br> <br>`50,179`<br>`10,907`<br>`23,952`<br>`72,807`<br>`32,955`<br>`190,800`|
||||||||||||||`2023`|`2022`|
||||||||||`Unrestricted`|||`Expendable`|`Totat`|`Total`|
|`7.`|`Cashatbankandinhand`||||||||`fund`<br>`£`|||`endowment`<br>`£`|`£`|`£`|
||`Cashinhand`||||||||||`-`|`10`|`10`|`10`|
||`BarclaysBankPLCcurrentaccount`||||||||||`-`|`22,390`|`22,390`|`5,313`|
||`JM Finncashdeposit`||||||||||`-`|`38,052`|`38,052`|`9,502`|
||`JMFinnincomeaccount`||||||||<br>|<br> <br>`4,718`<br>`4,718`||<br> <br>`(2,870)`<br>`57,582`|<br> <br>`1,848`<br>`62,300`|<br> <br>`1,050`<br>`15,875`|
||||||||||||||`2023`|`2022`|
||||||||||`Unrestricted`|||`Expendable`|`Total`|`Total`|
|`8.`|`Accruals`||||||||`fund`<br>`£`|||`endowment`<br>`£`|`£`|`£`|
||`GTCProbert- Hewitson'sfee`<br>`SafferyChampnessLLP.`||||||||<br>|<br> <br>`~`<br>`3,480`<br>`3,480`||<br> <br>`2,580`<br>`:`<br>`2,580`|<br> <br>`2,580`<br>`3,480`<br>`6,060`|<br> <br>`2,580`<br>`1,880`<br>`4,460`|
|`9.`|`Movementinfundsfortheyearto5 April2023`||||||||||||||
|||`Fund`||||`Co`||||||||`Fund`|
|||`balances`||`~`|`+`|`/`||||||||`balances`|
||`Fund`|`brought`|||`~~`||||||||`Gainsand`|`carried`|
|||`forward`|||`:`|`Income`|||`Expenditure`|||`Transfers`|`losses`|`forward`|
|||`£0.`|||||`£`||`E`|||`£`|`£`|`£`|
||`Expendableendowmentfund`|`202,835`|||||`52,757`||`(59,570)`|||`(2,450)`|`(34,012)`|`159,560`|
||`Unrestrictedfund`||`630`|||||`838`||`(2,680)`||`2,450`|`-`|`1,238`|
||<br>`Totalfunds`<br>|<br>`203,465`<br>||<br>|<br>|<br>|<br>`53,595`<br>||<br>`(62,250)`<br>|||<br>`-`<br>|<br>`(34,012)`<br>|<br>`160,798`<br>|



## 



|`Investmentsheldat5 April2023`|`No.of`<br>`shares`<br>`Cost`<br>`£`<br>`Market`<br>`value`<br>`£`<br>`Unrealised`<br>`profit/(loss`<br>`}`<br>`£`|`130`<br>`11,477`<br>`10,546`<br>`(15,796)`||`2,000`<br>`9,403`<br>`9,762`<br>`701`|`1,300`<br>`10,864`<br>`11,661`<br>`754`||`800`<br>`23,676`<br>`21,392`<br>`(2,600)`||`700`<br>`10,790`<br>`12,110`<br>`(1,232)`|`2,000`<br>`2,362`<br>`12,852`<br>`(7,788)`|`600`<br>`13,548`<br>`12,240`<br>`(3,420)`|||`750`<br>`13,311`<br>`13,995`<br>`(9,199)`|<br>`95,429`<br>`104,558`<br>`(38,581)`<br>||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|`Acquisitions/(disposals)`|`No.of`<br>`Cost/`<br>`Date`<br>`shares`<br>`}`<br>`£`<br>`(proceedsProfit/(loss`<br>`)onCost`<br>`£`|`20/04/22`<br>`240`<br>`03/01/23`<br>`(130)`<br>`16,578`<br>`9,051`<br>`4,219`<br>`(2,426)`||`06/12/22& `<br>`03/01/23`<br>`(3,000)`<br>`15,177`<br>`1,073`|||||||||`06/12/22& `|`03/01/23`<br>`(550)`<br>`11,464`<br>`1,703`|<br>`52,270`<br>`4,569`<br>|`Page9 `|
|`Investmentsheldat6 April2022`|`No.of`<br>`shares`<br>`Cost`<br>`£`<br>`Market`<br>`value`<br>`£`|`20`<br>`35,313`<br>`50,179`||`5,000`<br>`23,507`<br>`23,165`|`1,300`<br>`10,864`<br>`10,907`||`800`<br>`23,635`<br>`23,952`||`700`<br>`10,790`<br>`13,342`|`2000`<br>`2,362`<br>`20,640`|`600`<br>`13,548`<br>`15,660`|||`1,300`<br>`23,072`<br>`32,955`|<br>`143,090`<br>`190,800`<br>||
|`Holding`|`NorthAmerica`|`AmazonCommonStock`|`UK`|`AXAFramlingtonUnitManagementBiotechZ Acc`|`FinsburyGrowth& IncomeTrustORD`|`Europe`|`BaillieGifford& CoEuropeanB Acc`|`Global`|`HeraldInvestmentTrustORD`|`ScottishMortgageInvTrustOrdGBP0.25`|`HarbourvestGLBPRIEQORD`|`AlternativeStrategies`|`RITCapitalPartnersPLCORD`||`Total`||